Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
An announcement from Nanobiotix ( (NBTX) ) is now available.
Nanobiotix has announced the acquisition of shares by a key executive, Bartholomeus van Rhijn, which took place on December 9, 2024, at Euronext Paris. This transaction reflects the executive’s confidence in the company’s future prospects and could positively influence investor sentiment, given the significant volume of shares involved.
More about Nanobiotix
Nanobiotix is a company operating in the biopharmaceutical industry, focusing on developing nanomedicine products for cancer treatment. The company is known for its innovative approaches in enhancing radiotherapy efficacy using nanoparticles, targeting the oncology market.
YTD Price Performance: -53.30%
Average Trading Volume: 21,097
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $162.9M
For detailed information about NBTX stock, go to TipRanks’ Stock Analysis page.
Trending Articles
- ‘Get in for 2025 Gains,’ Says Cowen on Amazon Stock
- Top Analyst Sets the Stage for Nike Stock Ahead of Earnings
- Class Action Lawsuit Against Terran Orbital Corporation (LLAP)
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
